Location History:
- Kanagawa, JP (1993 - 1994)
- Kanagawa-ken, JP (1997 - 1999)
- Yokohama, JP (1984 - 2006)
Company Filing History:
14 out of 382 
8 out of 32 
1 out of 1 Years Active: 1984-2006
Title: The Innovations of Kiyoaki Katano: Pioneering Nitrogen-Containing Compounds for Health
Introduction: Kiyoaki Katano, based in Yokohama, Japan, has made substantial contributions to the field of medicinal chemistry through his inventive work. With a remarkable portfolio of 24 patents, he focuses on creating impactful compounds that address health concerns, particularly those related to lipid metabolism.
Latest Patents: Katano's latest innovations include his work on nitrogen-containing heterocyclic compounds and benzamide compounds that offer significant therapeutic potential. These compounds exhibit triglyceride biosynthesis inhibitory activity in the liver and prevent the secretion of apolipoprotein B-containing lipoproteins. Notably, they are designed to avoid the common side effects associated with lipid accumulation in the liver, making them suitable for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases. The formula (I) involves various configurations of alkyl, alkoxy, and other chemical groups, showcasing his expertise in creating versatile pharmacological agents.
Career Highlights: Throughout his career, Kiyoaki Katano has been associated with prestigious companies such as Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His work in these organizations has allowed him to push the boundaries of medicinal research, contributing to advancements that could enhance patient health outcomes.
Collaborations: Katano has collaborated with fellow researchers and inventors, including Takashi Tsuruoka and Hiroko Ogino. These partnerships have helped to foster a creative and innovative environment, leading to significant breakthroughs in the development of new pharmaceuticals.
Conclusion: Kiyoaki Katano's dedication to innovation in the field of medicinal chemistry underscores the importance of research and development in combating health challenges. His inventions not only exemplify scientific excellence but also highlight the potential for new therapies that can improve the quality of life for many individuals suffering from metabolic disorders. His continued efforts in this area promise to yield further advancements in pharmaceutical science.